Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Mar 10, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(March 8, 2005)
Last Price
(
March 1, 2005
)
% Change
Agilent
A
24.36
24.48
-0.49
Applied Biosystems
ABI
20.69
20.71
-0.10
BD
BDX
58.85
59.88
-1.72
Beckman
BEC
69.88
70.45
-0.81
Bio-Rad
BIO
48.51
49.60
-2.20
Bruker
BRKR
3.78
3.66
3.28
GE
GE
36.06
35.22
2.39
Harvard Bio
HBIO
4.43
4.22
4.98
Invitrogen
IVGN
71.66
70.56
1.56
Molecular Devices
MDCC
20.05
20.93
-4.20
PerkinElmer
PKI
23.01
22.20
3.65
Sigma
SIAL
63.79
62.37
2.28
Stratagene
STGN
7.39
6.82
8.36
Thermo
TMO
27.69
27.32
1.35
Waters
WAT
49.32
48.50
1.69
Index Average
35.30
35.13
0.48

 

Stratagene, Harvard Bio Lead as BCW Index Rises a Half Percent

Lifted by their fourth-quarter financial reports issued early this week, Stratagene and Harvard Bioscience shares closed up 8 percent and 5 percent, respectively, for the five-day period ending Tuesday.

The two companies were among nine of the 15 companies in the BioCommerce Week Index whose shares increased during the week.

PerkinElmer shares improved 3.7 percent for the week, followed by Bruker, which 3 percent after releasing its fourth-quarter financials and a raft of new products at last week's Pittcon (see article).

Molecular Devices led share-price losers with a 4 percent drop.

Overall, the Index finished up 0.5 percent, in positive territory for the second straight week with a close of $35.30. The Index has improved 13.5 percent since it debuted on Sept. 9, and reached a high-water mark of $36.10 on Feb. 8.

For the week, the BCW Index matched the Dow and the S&P 500, which were up 5 percent for the period, and outperformed the Nasdaq index, which closed level for the week, the Amex biotech index, which fell 3 percent, and the Amex pharma index, which was down over 0.5 percent.

 

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.